Emerging data suggests yes. Recent reviews reveal that AI-generated drugs achieve Phase I success rates of 80-90% , compared ...

Researchers from 25 countries presented their experience and expertise in the field of intelligent systems and AI ...

Hyderabad has appointed Prof U Deva Priyakumar as its new Dean of Research and Development, marking a leadership transition from Prof CV Jawahar, who served two consecutive terms. Prof Priyakumar is ...

The emergence of generative artificial intelligence tools has opened new doors for Australia's research community. The Sydney ...

Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in adeno-associated virus (AAV) gene therapy, today announced a major expansion of its artificial intelligence and machine learning ...

Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed with our AI-Immunology platformEVX-04 is a therapeutic cancer vaccine candidate ...

How is AI changing markets and investment strategy? We analyze how AI adoption across hardware, software, and enterprise services is reshaping markets and redefining market leadership in the next ...

Scientists found a new coronavirus in Brazilian bats, named BRZ batCoV. This virus shares a genetic feature with SARS-CoV-2, the virus causing COVID-1 ...

Learn how labman is advancing biologics manufacturing through AI-powered bioreactor technology, driving innovation in drug ...

The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.

The three-day event featured 80 research presentations, 3 keynote lectures, and several special sessions and workshops ...

Scientific knowledge is fundamentally built on data; yet, for too long, research datasets have remained siloed, poorly ...